Causes and Outcomes of Community Acquired Pneumonia — CAP  

Community Acquired Pneumonia Clinical Trial

Official title: Etiology, Clinical Manifestations and Risk Factors for Community-acquired Pneumonia in Patients Admitted to Hospital

Status Completed

Clinical Trial Summary

This is a descriptive clinical research aiming:

• To describe the clinical spectrum and clinical characteristics of community acquired pneumonia (CAP) in patients admitted to hospital

• To identify the etiology of CAP and the antibiotic sensitivity of the isolated organisms

• To identify the risk factors that influence the severity of CAP

Clinical Trial Description

In Vietnam, the range and relative contribution of organisms causing CAP remain unclear, largely because diagnostic tools are limited and clinical research uncommon. An improved understanding of the risk factors, etiology and clinical outcomes of CAP in Vietnam would contribute to improved approaches to patient diagnosis and clinical management. This will be achieved by following the clinical and laboratory progress and treatment outcomes of in-patients diagnosed with CAP from admission to discharge. Comparative analyses will be between subgroups including survivor and non-survivor, severe CAP and non-severe CAP, known etiology and unknown etiology, SIRS, sepsis, severe sepsis and shock septic. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Community Acquired Pneumonia
• Pneumonia

• NCT number: NCT01336036
• Study type: Observational
• Source: Oxford University Clinical Research Unit, Vietnam
• Status: Completed
• Phase: N/A
• Start date: February 2011
• Completion date: February 2014